RB

Rajan Bhan

Active Director Director DIN 02358104
DIN 02358104 First appointment Dec 2005 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2005
Shareholding value •••• Premium profile

About Rajan Bhan

Data last updated:

Rajan Bhan is a Director at Recova Biotech Private Limited (since 2005). The company operates in Trading. Recova Biotech Private Limited reported revenue of ₹49.3 Lakh (FY 2025).

DIN 02358104
Primary Designation Director
Industry Trading
First Appointment 07 Dec 2005
Oldest Company Age 20 yrs
Largest company Recova Biotech Private Limited · ₹49.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Recova Biotech Private Limited U51397JK2005PTC002594
Director07 Dec 20052005₹49.3 Lakh (FY 2025)Active

Board colleagues of Rajan Bhan

NameDINCompanyDesignation
Ranjna Bhan02358120Recova Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Recova Biotech Private Limited
Premium access

Shareholding and investment profile for Rajan Bhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajan Bhan

Rajan Bhan currently holds 1 directorship: Recova Biotech Private Limited (Director, since 07 Dec 2005, revenue ₹49.3 Lakh (FY 2025)).

Rajan Bhan was first appointed on 07 Dec 2005 as Director at Recova Biotech Private Limited.

The current boards of Rajan Bhan's companies include Ranjna Bhan (Recova Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available